M. Weisman

Recombinant Human Relaxin in the Treatment of Scleroderma

L. Moreland, R. Simms, J. Korn, 2000, Annals of Internal Medicine.

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

P. Lipsky, F. Breedveld, D. Furst, 1999, The Lancet.

Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

M. Urowitz, I. Russell, G. Alarcón, 1992, Arthritis and rheumatism.

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.

J. Kremer, M. Weisman, D. Furst, 1998, Arthritis and rheumatism.

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.

M. Weisman, D. Furst, L. Moreland, 1999, Arthritis and rheumatism.

Chondrex: new marker of joint disease.

J. O'dell, C. Swindlehurst, M. Krusemeier, 1998, Clinical chemistry.

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.

Richard W. Martin, M. Mayes, D. Furst, 2004, Seminars in arthritis and rheumatism.